DENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Lowered by Wall Street Zen

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

XRAY has been the topic of a number of other reports. Weiss Ratings restated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. UBS Group cut their target price on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating on the stock in a research note on Friday, August 8th. Wells Fargo & Company cut their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Friday, August 8th. Evercore ISI cut their target price on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research note on Wednesday, October 8th. Finally, Barrington Research cut their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating on the stock in a research note on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $18.00.

DENTSPLY SIRONA Stock Down 0.9%

Shares of XRAY opened at $12.51 on Friday. The stock has a market capitalization of $2.50 billion, a PE ratio of -2.64, a P/E/G ratio of 0.78 and a beta of 0.96. DENTSPLY SIRONA has a 1 year low of $11.69 and a 1 year high of $24.86. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The company’s 50-day simple moving average is $13.38 and its 200-day simple moving average is $14.52.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million for the quarter, compared to analysts’ expectations of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business’s quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds have recently added to or reduced their stakes in XRAY. Wealth Enhancement Advisory Services LLC increased its stake in DENTSPLY SIRONA by 39.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 53,903 shares of the medical instruments supplier’s stock valued at $805,000 after purchasing an additional 15,117 shares during the last quarter. Janney Montgomery Scott LLC increased its stake in DENTSPLY SIRONA by 210.5% in the first quarter. Janney Montgomery Scott LLC now owns 64,191 shares of the medical instruments supplier’s stock valued at $959,000 after purchasing an additional 43,516 shares during the last quarter. Blue Trust Inc. increased its stake in DENTSPLY SIRONA by 57.7% in the first quarter. Blue Trust Inc. now owns 12,554 shares of the medical instruments supplier’s stock valued at $188,000 after purchasing an additional 4,595 shares during the last quarter. Lecap Asset Management Ltd. purchased a new position in DENTSPLY SIRONA in the first quarter valued at approximately $761,000. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of DENTSPLY SIRONA in the first quarter valued at approximately $25,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.